Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.
about
How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis VaccinesMonoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activityPhase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.Review of meningococcal group B vaccines.Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates.Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humansAntibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.Seroprevalence of Antibody-Mediated, Complement-Dependent Opsonophagocytic Activity against Neisseria meningitidis Serogroup B in England.The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera.Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infantsRelative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease.Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source.Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults.
P2860
Q26782340-98B436CD-ACA0-4737-8866-11C0BAAD6DDEQ28730934-0DDEAD0B-E110-422A-887E-57E3B6A46076Q30227840-EA9EB028-D139-4584-A20F-6E88AD3B7171Q33613839-3766AF2F-BD13-4FAC-B8F4-4E01595C946DQ33646965-D9E472C6-8719-4B29-ACA7-57EF538F6C15Q33695485-FB8752B2-6F94-4CC4-BADF-03DB19E4F9B8Q33734798-754ABE1A-5F93-4A1B-9216-96E8CFAAB873Q35122775-7B648D7E-B144-42AE-8B2B-BBFB5FE84656Q35273041-5B9CB1E4-90F8-42B4-B58B-DEDC5FCEEA9EQ35548013-1961D729-ACF8-4306-ACC8-D98BFC08ABC7Q35989852-2325A1E4-04E1-4FE3-B007-720A6A4969FBQ37075472-60C782BF-09D8-41A4-AC63-556FAB9389FCQ37131083-04E987DA-0270-48FE-9C17-C503A286CD0FQ37362174-8C4A93A2-D7C0-41AA-8BF0-2A17CAC9A2F8Q37531323-65E4E73C-3982-4AFA-8B6E-682858AB35A0Q37798011-EC7E1945-D3DC-4DC8-B41E-49D5D35D359BQ40408137-6A1FDB08-AB68-41E7-87CE-D59C361A1CF3Q41012990-681CA0EB-A59F-42A0-8DE4-F8C169A0BC94Q42173007-464EFD4A-E94D-4BA6-9F69-F33191144813Q47576940-FBCB9BBA-56FB-4F9B-9412-75BA60B8831FQ48255838-334A7268-59F4-432D-BF22-88FEFD766F9B
P2860
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.
@ast
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.
@en
type
label
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.
@ast
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.
@en
prefLabel
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.
@ast
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.
@en
P2860
P356
P1476
Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.
@en
P2093
D M Granoff
J S Plested
P2860
P304
P356
10.1128/CVI.00036-08
P577
2008-03-19T00:00:00Z